Clinical Trial Update: Sirolimus for Graves' Orbitopathy (GO) [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating sirolimus for Graves' Ophthalmopathy is in a phase 2 study with unknown status.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Graves Ophthalmopathy

Drugs mentioned

• Sirolimus (Sirolimus)

Snippet

Sponsor: University of Pisa | Conditions: Graves Ophthalmopathy | Phase 2 | Status: UNKNOWN